Navigation Links
MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States
Date:5/28/2009

HALIFAX, May 28 /PRNewswire-FirstCall/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that VWR International, LLC (VWR) has joined the Company's U.S. distribution network. Headquartered in West Chester, Pennsylvania, VWR is a global laboratory supply and distribution company with worldwide sales in excess of $3.7 billion.

"The U.S. is an important market for MedMira and building out our distribution network is a key initiative in maintaining and expanding our market position. Adding VWR to our U.S. distribution network will increase our sales revenues and enable us to fully capitalize on opportunities to launch new products in the market," said Hermes Chan, CEO, MedMira. "VWR will work with MedMira's U.S.-based sales and marketing partner American Health Diagnostics (AHD) to expand sales for our Reveal G3 rapid HIV test and identify opportunities for new MedMira products."

"We provide our customers with the most innovative products available on the market today. Adding MedMira's 3-minute rapid HIV test to our product portfolio will provide our U.S. customers with a critical diagnostic tool," said Mark McLoughlin, Senior Vice President, Category Management North America, VWR.

About MedMira

MedMira is a leading developer and manufacturer of flow-through rapid diagnostics. The company's tests provide hospitals, labs, clinics and individuals with reliable, rapid diagnosis for diseases such as HIV and hepatitis C in just three minutes. The company's tests are sold under the Reveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in global markets. MedMira's rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union. MedMira's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada. For more information visit MedMira's website at www.medmira.com.

This news release contains forward-looking statements, which involve risk and uncertainties and reflect the company's current expectation regarding future events. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings.

The TSX Venture Exchange has not reviewed and does not accept

responsibility for the adequacy or accuracy of this statement.


'/>"/>
SOURCE MEDMIRA INC.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Medpace Strengthens Presence in Central Europe
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
4. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
5. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
6. Anavex strengthens Board of Directors
7. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
8. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
9. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
10. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017   Sienna Biopharmaceuticals, Inc. ... company, today announced that Richard Peterson will ... 24.   Peterson, who brings more than two ... Smither , who is retiring at the end of ... advisory capacity. Peterson joins Sienna from Novan, Inc., where ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... exhibits both viscous and elastic characteristics when deformed, which is identical to how ... to gently absorb compressive forces and return to its natural state along a ...
(Date:3/23/2017)... , Mar 23, 2017 Research ... Products: Global Markets" report to their offering. ... The Global ... $466.6 Billion in 2016 at a CAGR of 8.9%, ... energetic and non-energetic bioproducts into seven major product segments: bio-derived ...
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
Breaking Biology Technology:
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/22/2017)... , March 21, 2017 Vigilant ... company serving law enforcement agencies, announced today the appointment ... as director of public safety business development. ... law enforcement experience, including a focus on the aviation ... his most recent position, Mr. Sheridan served as the ...
Breaking Biology News(10 mins):